Wellington Partners

Wellington Partners is a Munich-based venture capital firm, focusing on early- and growth-stage investments in life sciences. Established in 1998, the firm has been instrumental in backing innovative companies in biotechnology, medical devices, digital health, and diagnostics across Europe. With over €1.2 billion under management, including €590 million dedicated specifically to life sciences, Wellington Partners has a robust track record of supporting breakthrough technologies aimed at improving healthcare. Their portfolio includes successful companies like Carisma Therapeutics, Onward Medical, and Symetis, many of which have achieved successful IPOs or acquisitions. Wellington's investment strategy goes beyond capital infusion, offering extensive operational support and access to their global network to help startups navigate regulatory approvals, clinical development, and market expansion. The firm typically invests in the range of €0.5 million to €20 million per company and plays a hands-on role in scaling businesses globally, with a strong presence in key markets like Europe and the U.S. Through their dedicated team of MDs and PhDs, Wellington Partners continues to drive transformative healthcare innovations.